https://www.avient.com/sites/default/files/2021-04/avient-colorants-netherlands-b.v.-extract-coc-apr-12-2021.pdf
Corporate seat Amsterdam First entry in Business Register 12-04-2006 Date of deed of incorporation 11-04-2006 Date of deed of last amendment to the Articles of Association 12-04-2021 Issued capital EUR 19.593,63 Paid-up capital EUR 19.593,63 Filing of the annual accounts The annual accounts for the financial year 2019 were filed on 01-07-2020.
https://www.avient.com/sites/default/files/2021-11/avient-s.a-r.l.-belgium-branch-extract-cbe-0700822426-26-november-2021.pdf
Belgium Branch Vesaliusstraat 31 - 1000 Brussels E: ol.brussel@xerius.be T: 02 609 62 30 Inne Tuyteleers Officer Xerius Enterprise Counter 26/11/2021 4Extract from Page 2from Functions Last Name, first Name Registered entity Start Date End DateReason for termination Representative (branch) Roels Jean-Marie 31/08/2018 Last Name, first Name Registered entity Start Date End DateReason for terminationEntrepreneurial skills - Ambulant commerce - Fairground operator 31/08/2018Non SME dispensation (Exemption) Characteristic Phase Duration Start Date End DateReason for termination Employer National Social Security Office Characteristic/authorisation acquired 01/11/2018undetermined Subject to VAT Characteristic/authorisation acquired 31/08/2018undetermined Enterprise subject to registration Characteristic/authorisation acquired 01/11/2018undetermined General assembly End Date Financial Year Start Date Exceptional Year Start Date End DateEnd Date Exceptional Year Financial Details Share capital (Capital Stock) Currency Duration of the entity 12,000.00 EUR June 31/12 09/08/2018 Use Bank account number Start Date End DateBank account number Bank Accounts BIC For all purposes 685 8477013 57 31/08/2018BE09685847701357BOFABE3X External Identifiers NSSO number 143954886 Trade register number 19 0097620 There is no data available for the following sections: Authorisations, Working partners :, Ex-officio striking off, Links between registered entities List of branches Branch - Center of operations General Information Start date entity End date entity 09/08/2018 Address Start Date End Date Address Rue Melville Wilson 2 09/08/2018 5330 Assesse België Company Number 0700.822.426 Company Name Avient S.à r.l., Belgium Branch Inne Tuyteleers Officer Xerius Enterprise Counter 26/11/2021 4Extract from Page 3from Establishment unit number Name Situation on 2.278.618.585 Avient S.à r.l., Belgium Branch 26/11/2021 Name Type Language Name Start Date End Date Trade name French Avient S.à r.l., Belgium Branch 08/11/2021 Address Start Date End Date Address Rue Melville Wilson 2 31/08/2018 5330 Assesse België Additional address info Contact details Type Contact detail Characteristic Start Date End Date Website www.polyone.com Declarative 31/08/2018 General Information 31/08/2018Start date establishment unit End date establishment unit Start date link between entities End date link between entities 31/08/2018 Activities Type Start Date End DateVersionNACEBEL Activities Wholesale trade of industrial chemical products Main activity 31/08/2018200846751 Wholesale trade of industrial chemicals: aniline, printing ink, essential oils, industrial gases, chemical glues, dyes, synthetic resin, methanol, paraffin, etc.
https://www.avient.com/sites/default/files/2021-09/avient2020sustainabilityreport-9-2-21.pdf
We do this through our safety focus, benefits, and wellness programs that support financial, physical and mental wellness.
Goff Former Chairman, President and Chief Executive Officer, Andeavor Ernest Nicolas Senior Vice President and Chief Supply Chain Officer, Rockwell Automation Richard Fearon Lead Director, Avient Corporation Retired Vice Chairman and Chief Financial and Planning Officer, Eaton William R Jellison Retired Vice President, Chief Financial Officer, Stryker Corporation Kerry J.
Financial information referenced here is provided to aid in reconciling back to the most comparable GAAP figures.
https://www.avient.com/sites/default/files/2024-08/Avient 2023 Sustainability Report_6.pdf
Richard Fearon Non-Executive Chairman, Avient Corporation Retired Vice Chairman and Chief Financial and Planning Officer, Eaton William R Jellison Retired Vice President, Chief Financial Officer, Stryker Corporation Kerry J.
Financial information referenced here is provided to aid in reconciling back to the most comparable GAAP figures.
Financial information referenced here is provided to aid in reconciling back to the most comparable GAAP figures.
https://www.avient.com/sites/default/files/2024-08/Avient-2023-Sustainability-Report_5.pdf
Richard Fearon Non-Executive Chairman, Avient Corporation Retired Vice Chairman and Chief Financial and Planning Officer, Eaton William R Jellison Retired Vice President, Chief Financial Officer, Stryker Corporation Kerry J.
Financial information referenced here is provided to aid in reconciling back to the most comparable GAAP figures.
Financial information referenced here is provided to aid in reconciling back to the most comparable GAAP figures.
https://www.avient.com/sites/default/files/resources/Proxy%2520Statement%2520for%2520Web%2520Hosting.pd_.pdf
COMPENSATION DISCUSSION AND ANALYSIS Factor Median Peer Group Comparator 2017 Financials* 2018 PolyOne Results PolyOne Peer Group for 2018 Compensation Decisions Review of 2018 Named Executive Officer Compensation COMPENSATION DISCUSSION AND ANALYSIS What We Pay and Why: Elements of Compensation 2018 Base Salary 2018 Annual Incentive.
Richardson, Executive Vice President, Chief Financial Officer Robert M.
Exercise or Base Price of Option Awards (column (i)) Grant Date Fair Value of Stock and Option Awards (column (j)) Narrative Disclosure Relating to the 2018 Summary Compensation Table and the 2018 Grants of Plan-Based Awards Table Outstanding Equity Awards at 2018 Fiscal Year-End Option Exercise Price ($) (e) Option Expiration Date (f) Market Value of Shares or Units of Stock That Have Not Vested ($) (h) Equity Incentive Plan Awards: Market or Payout Value of Unearned Shares, Units or Other Rights that Have Not Vested ($) (j) Name (a) Stock Awards Equity Incentive Plan Awards: Number of Securities Underlying Unexercised Unearned Options (#) (d) Equity Incentive Plan Awards: Number of Unearned Shares, Units or Other Rights that Have Not Vested (#) (i) Number of Shares or Units of Stock That Have Not Vested (#) (g) Number of Securities Underlying Unexercised Options (#) Unexercisable (c) Number of Securities Underlying Unexercised Options (#) Exercisable (b) Option Awards EXECUTIVE COMPENSATION EXECUTIVE COMPENSATION Number of Securities Underlying Unexercised Options (#) Exercisable (column (b)) Number of Securities Underlying Unexercised Options (#) Unexercisable (column (c)) Equity Incentive Plan Awards: Number of Securities Underlying Unexercised Unearned Options (column (d)) Option Exercise Price (column (e)) Option Expiration Date (column (f)) Number of Shares or Units of Stock That Have Not Vested (column (g)) Market Value of Shares or Units of Stock That Have Not Vested (column (h)) Equity Incentive Plan Awards: Number of Unearned Shares, Units or Other Rights That Have Not Vested (column (i)) EXECUTIVE COMPENSATION Equity Incentive Plan Awards: Market or Payout Value of Unearned Shares, Units or Other Rights That Have Not Vested (column (j)) 2018 Option Exercises and Stock Vested Name (a) Option Awards Stock Awards Number of Shares Acquired on Exercise (#) (b) Value Realized on Exercise ($) (c) Number of Shares Acquired on Vesting (#) (d) Value Realized on Vesting ($) (e) Option Awards (columns (b) and (c)) Stock Awards (columns (d) and (e)) 2018 Nonqualified Deferred Compensation EXECUTIVE COMPENSATION Name Aggregate Executive Registrant Aggregate Aggregate Aggregate Balance at Contributions Contributions Earnings Withdrawals/ Balance at in Last FY in Last FY in Last FY Distributions Last FYE (1) ($)(2) ($)(3) ($)(4) ($) ($)(1)(5) Potential Payments Upon Termination or Change of Control Summary of Potential Payments EXECUTIVE COMPENSATION Management Continuity Agreements Executive Severance Plan EXECUTIVE COMPENSATION Annual Plan Long-Term Incentive Awards Retirement Benefits Payments and Benefits Upon Termination — As of the End of Fiscal Year 2018 EXECUTIVE COMPENSATION EXECUTIVE COMPENSATION CEO Pay Ratio Disclosure CEO Annual Total Compensation for 2018: $6,127,920 Median Employee Annual Total Compensation for 2018: $48,056 Ratio of CEO to Median Employee Annual Total Compensation for 2018: 128:1 How the Median Employee was Determined in 2017 EXECUTIVE COMPENSATION Compensation Committee Interlocks and Insider Participation Policy on Related Person Transactions Risk Assessment of the Compensation Programs EXECUTIVE COMPENSATION Compensation Committee Report The Compensation Committee of the Board of Directors MISCELLANEOUS MISCELLANEOUS PROVISIONS Voting at the Meeting not Shareholder Proposals MISCELLANEOUS Proxy Solicitation We will furnish without charge to each person from whom a proxy is being solicited, upon written request of any such person, a copy of the Annual Report on Form 10-K of the Company for the fiscal year ending December 31, 2018, as filed with the SEC, including the financial statements and schedules thereto.
https://www.avient.com/sites/default/files/2024-05/3b - Corporate Governance Guidelines.Draft Feb. 2024.v1.2.Revised.4-16-24.Final_.pdf
The Board has delegated specific risk oversight responsibility to the committees of the Board as follows: (i) the Audit Committee oversees risks related to the Company’s financial statements, financial reporting processes, internal controls, information technology, and cybersecurity; (ii) the Compensation Committee oversees risks related to the Company’s compensation programs; (iii) the Governance and Corporate Responsibility Committee oversees risks related to the Company’s programs, policies, and practices related to certain sustainability and governance matters, including a review of the Company’s Sustainability Report; and (iv) the Environmental, Health and Safety Committee oversees risks related to safety, health, physical security, environmental, and product stewardship matters.
The Board and its Committees may, in appropriate circumstances and at Company expense, consult and retain independent legal, financial or other advisors. 4.
https://www.avient.com/sites/default/files/resources/Investor%2520Day%2520-%2520May%25202012%2520-%2520Welcome%2520and%2520Introduction.pdf
Rosenau Financial Review Richard J.
https://www.avient.com/sites/default/files/resources/Application%2520Bulletin%2520Resilience%2520HC.pdf
Because insurance companies and Medicare will no longer reimburse the costs associated with HAI’s, the financial burden, estimated at $14,000 per infection, falls on the patient or hospital.
https://www.avient.com/sites/default/files/resources/Investor%2520Day%2520-%2520May%25202012%2520-%2520Financial%2520Review.pdf
Microsoft PowerPoint - Investor Day 2012_05072012.pptx Financial Review Richard J.